Intraventricular Administration of Rhenium-186 NanoLiposome for Leptomeningeal Metastases
NCT05034497
·
clinicaltrials.gov ↗
PHASE1
Phase
ACTIVE_NOT_RECRUITING
Status
18
Enrollment
INDUSTRY
Sponsor class
Conditions
Leptomeningeal Metastasis
Interventions
DRUG:
186RNL
Sponsor
Plus Therapeutics